New Pharma Code 2024 Requires Ethics Officers and Expense Disclosure
The Pharmaceutical Department announced on April 12, 2024 that the Uniform Code for Pharmaceutical Marketing Practices (UCPMP) 2024 replaces the earlier 2015 version. An amendment in September 2025 further tightened the rules.
Key updates include the compulsory formation of an Ethics Committee (ECPMP) and the appointment of an Ethics Officer to oversee all promotional activities. Firms must also maintain a transparent record of their annual marketing spend and upload it to the designated portal each year.
The updated code strengthens guidelines governing interactions between drug companies, health‑care professionals and institutions. It explicitly bars the distribution of gifts, cash benefits, or hospitality to physicians, their relatives, or medical representatives.
By introducing a mandatory self‑declaration and a structured grievance redressal mechanism, the government seeks to enforce responsible drug promotion while protecting patient interests.